Trial intelligence / Profile preview

TeACH-R

NCT02056444Completed

Start
Feb 2014
Primary completion
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of tranexamic acid in Not applicable (2 arms). Primary endpoints: Delta-hemoglobin and Calculated blood loss. Started Feb 2014; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Not applicable

Beyond the preview

Go deeper on NCT02056444.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02056444.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call